Free Trial
FRA:SRT3

Sartorius Aktiengesellschaft (SRT3) Stock Price, News & Analysis

€228.60
-9.60 (-4.03%)
(As of 10/16/2024 ET)

About Sartorius Aktiengesellschaft Stock (FRA:SRT3)

Key Stats

Today's Range
€223.90
€233.60
50-Day Range
€228.60
€253.30
52-Week Range
€71.00
€124.70
Volume
149,015 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products. In addition, the company offers water purification systems; surface plasmon resonance; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, equipment manufacturer cells, weights and weight sets, paint mixing solutions, and weighing accessories; and process filtration. Further, the company provides bioprocess consulting and engineering, biologics testing, media and process, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.

Receive SRT3 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

SRT3 Stock News Headlines

Here's what to expect from Sartorius's earnings
The most serious warning of my career
With the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the financial world in two the moment the polls close. I predict they could see investment losses of 50% (or more) in the weeks following the presidential election.
Sartorius Aktiengesellschaft (SRT3.VI)
Tayler A. Sartorius
SATG_p Historical Data
See More Headlines

SRT3 Stock Analysis - Frequently Asked Questions

Sartorius Aktiengesellschaft's stock was trading at €333.20 at the start of the year. Since then, SRT3 stock has decreased by 31.4% and is now trading at €228.60.
View the best growth stocks for 2024 here
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sartorius Aktiengesellschaft investors own include NVIDIA (NVDA), Alliance Data Systems (ADS), Bayer Aktiengesellschaft (BAYN), Tesla (TSLA), Texas Instruments (TXN), Abbott Laboratories (ABT) and Accenture (ACN).

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
14,143
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (FRA:SRT3) was last updated on 10/17/2024 by MarketBeat.com Staff
From Our Partners